131 related articles for article (PubMed ID: 22398564)
1. Apolipoprotein E ε4 status modifies the effects of sex hormones on neuropsychiatric symptoms of Alzheimer's disease.
Xing Y; Qin W; Li F; Jia XF; Jia J
Dement Geriatr Cogn Disord; 2012; 33(1):35-42. PubMed ID: 22398564
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease.
van der Flier WM; Staekenborg S; Pijnenburg YA; Gillissen F; Romkes R; Kok A; Bouwman FH; Scheltens P
Dement Geriatr Cogn Disord; 2007; 23(1):42-6. PubMed ID: 17077632
[TBL] [Abstract][Full Text] [Related]
3. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P
Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371
[TBL] [Abstract][Full Text] [Related]
4. Sex Differences in Neuropsychiatric Symptoms of Alzheimer's Disease: The Modifying Effect of Apolipoprotein E ε4 Status.
Xing Y; Tang Y; Jia J
Behav Neurol; 2015; 2015():275256. PubMed ID: 26538817
[TBL] [Abstract][Full Text] [Related]
5. The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.
D'Onofrio G; Panza F; Seripa D; Sancarlo D; Paris F; Cascavilla L; Urbano M; Gravina C; Fontana A; Solfrizzi V; Pellegrini F; Pilotto A
Int J Geriatr Psychiatry; 2011 Oct; 26(10):1062-70. PubMed ID: 21905100
[TBL] [Abstract][Full Text] [Related]
6. Modification of estrogen's association with Alzheimer's disease risk by genetic polymorphisms.
Thornton V; Warden D; Talbot C; Mastana SS; Bandelow S; Hogervorst E
Brain Res; 2011 Mar; 1379():213-23. PubMed ID: 21211518
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
[TBL] [Abstract][Full Text] [Related]
8. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
9. The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase.
Darreh-Shori T; Modiri N; Blennow K; Baza S; Kamil C; Ahmed H; Andreasen N; Nordberg A
Neurobiol Aging; 2011 Jul; 32(7):1236-48. PubMed ID: 19713000
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
11. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
[TBL] [Abstract][Full Text] [Related]
12. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.
Panza F; Frisardi V; Seripa D; D'Onofrio G; Santamato A; Masullo C; Logroscino G; Solfrizzi V; Pilotto A
Ageing Res Rev; 2012 Jan; 11(1):87-103. PubMed ID: 21763789
[TBL] [Abstract][Full Text] [Related]
14. Associations between sex hormones and cognitive and neuropsychiatric manifestations in vascular dementia (VaD).
Xing Y; Qin W; Li F; Jia XF; Jia J
Arch Gerontol Geriatr; 2013; 56(1):85-90. PubMed ID: 23103091
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.
Varges D; Jung K; Gawinecka J; Heinemann U; Schmitz M; von Ahsen N; Krasnianski A; Armstrong VW; Zerr I
J Alzheimers Dis; 2011; 23(4):717-26. PubMed ID: 21157024
[TBL] [Abstract][Full Text] [Related]
16. Association of apolipoprotein E ε4 (ApoE ε4) homozygosity with psychiatric behavioral symptoms.
Michels A; Multhammer M; Zintl M; Mendoza MC; Klünemann HH
J Alzheimers Dis; 2012; 28(1):25-32. PubMed ID: 22246233
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study.
Steinberg M; Corcoran C; Tschanz JT; Huber C; Welsh-Bohmer K; Norton MC; Zandi P; Breitner JC; Steffens DC; Lyketsos CG
Int J Geriatr Psychiatry; 2006 Sep; 21(9):824-30. PubMed ID: 16955439
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development.
Burke SL; Maramaldi P; Cadet T; Kukull W
Arch Gerontol Geriatr; 2016; 65():231-8. PubMed ID: 27111252
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
